Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

News You Need to Know Today
The future of echocardiography | The economics of TAVR | Cardiologist gets jail time for abusing infant son
Monday, February 28, 2022
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

Today's News and Trends

Q&A: William Zoghbi breaks down the future of echocardiography

In a new interview, former ACC and ASE President William A. Zoghbi, MD, reviews some of the biggest trends in cardiac ultrasound.

READ MORE >
The mitral valve seen on 3D cardiac ultrasound offers a noninvasive surgeon's view of the valve for better diagnostics and pre-planning of structural heart procedures. Example from the GE Vivid E95 FlexiLight photo-realistic 3D/4D lighting system.
Share on Twitter Share on Facebook Share on Linkedin

Q&A: William Zoghbi breaks down the future of echocardiography

Share on Twitter Share on Facebook Share on Linkedin
The mitral valve seen on 3D cardiac ultrasound offers a noninvasive surgeon's view of the valve for better diagnostics and pre-planning of structural heart procedures. Example from the GE Vivid E95 FlexiLight photo-realistic 3D/4D lighting system.
In a new interview, former ACC and ASE President William A. Zoghbi, MD, reviews some of the biggest trends in cardiac ultrasound.
READ MORE >

TAVR associated with lower healthcare costs than surgery

Researchers examined Medicare data from 2016 to 2018, presenting their findings in Circulation: Cardiovascular Interventions. 

READ MORE >
The Edwards Lifesciences Sapien transcatheter aortic valve replacement (TAVR) device in a heart model used to show patients how the device works.
Share on Twitter Share on Facebook Share on Linkedin

TAVR associated with lower healthcare costs than surgery

Share on Twitter Share on Facebook Share on Linkedin
The Edwards Lifesciences Sapien transcatheter aortic valve replacement (TAVR) device in a heart model used to show patients how the device works.
Researchers examined Medicare data from 2016 to 2018, presenting their findings in Circulation: Cardiovascular Interventions. 
READ MORE >

‘I’m a monster’: New York cardiologist sentenced to 3 years in prison for assaulting infant son

The incident occurred in August 2020, when the child was four weeks old. 

READ MORE >
offender-trouble-handcuffs-police-arrest-2102488.jpg
Share on Twitter Share on Facebook Share on Linkedin

‘I’m a monster’: New York cardiologist sentenced to 3 years in prison for assaulting infant son

Share on Twitter Share on Facebook Share on Linkedin
offender-trouble-handcuffs-police-arrest-2102488.jpg
The incident occurred in August 2020, when the child was four weeks old. 
READ MORE >

Featured Articles

New CDC guidance: Waiting longer between COVID-19 vaccine doses could reduce risk of heart damage

Waiting a few additional weeks, the agency wrote, could help limit myocarditis or pericarditis among young adults.

READ MORE >
Myocarditis as seen on cardiac MRI in patients who recently received COVID-19 messenger RNA vaccination from a November 2021 imaging study. Image courtesy of the American Journal of Roentgenology (AJR)
Share on Twitter Share on Facebook Share on Linkedin

New CDC guidance: Waiting longer between COVID-19 vaccine doses could reduce risk of heart damage

Share on Twitter Share on Facebook Share on Linkedin
Myocarditis as seen on cardiac MRI in patients who recently received COVID-19 messenger RNA vaccination from a November 2021 imaging study. Image courtesy of the American Journal of Roentgenology (AJR)
Waiting a few additional weeks, the agency wrote, could help limit myocarditis or pericarditis among young adults.
READ MORE >

Recurrent MR after TEER: Tracking data from nearly 700 MitraClip patients

The new analysis focused on both primary and secondary MR 12 months after TEER. 

READ MORE >
The Abbott MitraClip is the primary structural heart device used in transcatheter edge-to-edge repairs (TEER) of the mitral valve leaflets. The results of the COAPT trial dropped like a thunderclap Sunday at the Transcatheter Cardiovascular Therapeutics (TCT) annual meeting, with several cardiologists predicting the MitraClip device will have a swift and lasting impact on the treatment of heart failure patients.
Share on Twitter Share on Facebook Share on Linkedin

Recurrent MR after TEER: Tracking data from nearly 700 MitraClip patients

Share on Twitter Share on Facebook Share on Linkedin
The Abbott MitraClip is the primary structural heart device used in transcatheter edge-to-edge repairs (TEER) of the mitral valve leaflets. The results of the COAPT trial dropped like a thunderclap Sunday at the Transcatheter Cardiovascular Therapeutics (TCT) annual meeting, with several cardiologists predicting the MitraClip device will have a swift and lasting impact on the treatment of heart failure patients.
The new analysis focused on both primary and secondary MR 12 months after TEER. 
READ MORE >

FDA approves empagliflozin for reducing risk of cardiovascular death, hospitalization among adult HFpEF patients

The SGLT2 inhibitor, already approved for some high-risk heart failure patients, has now received a much wider approval. 

READ MORE >
approved approval safe
Share on Twitter Share on Facebook Share on Linkedin

FDA approves empagliflozin for reducing risk of cardiovascular death, hospitalization among adult HFpEF patients

Share on Twitter Share on Facebook Share on Linkedin
approved approval safe
The SGLT2 inhibitor, already approved for some high-risk heart failure patients, has now received a much wider approval. 
READ MORE >

In Other News

Patient demand for telemedicine remains strong

Clinicians and health systems have had more time to optimize their telemedicine practices, contributing to an increase in telemedicine’s overall favorability among patients, according to a report by Doximity. 

READ MORE >
A patient has a telehealth visit with their doctor remotely in their home via video conferencing. The COVID-19 cause massive movement to telehealth since 2020.
Share on Twitter Share on Facebook Share on Linkedin

Patient demand for telemedicine remains strong

Share on Twitter Share on Facebook Share on Linkedin
A patient has a telehealth visit with their doctor remotely in their home via video conferencing. The COVID-19 cause massive movement to telehealth since 2020.
Clinicians and health systems have had more time to optimize their telemedicine practices, contributing to an increase in telemedicine’s overall favorability among patients, according to a report by Doximity. 
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

TAVR for moderate aortic stenosis | BP drug recalled | Stroke prevention device fails | New Medicare cuts | CCTA-guided PCI
A new way to think about the heart health of women | GLP-1 drugs vs. metformin | Cannabis use may increase risk of CVD, stroke
New Medicare payment cuts | Telemedicine vs. in-person cardiology visits | FDA confirms Class I recall | Startup raises $160M
FDA approves transcatheter treatment for PVL | CCTA-guided PCI | Real-world RDN outcomes | J&J launches new IVL catheter
CCTA vs. IVUS for PCI guidance: Carlos Collet reviews the data | The real-world benefits of RDN | New TAVR tech falls short
TAVR Highlights: New data on treating moderate AS | CMS may expand coverage again | Is surgical backup still necessary?
GLP-1 drugs vs. metformin | BP drug recalled | The health risks of cannabis use | Energy drinks linked to heart issues
Newsletter archive
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
  • Press Releases
  • Submit Press Release
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
Design by Adaptive Theme